Corrigendum.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12287
- Publication type:
- Article
Works matching IS 17555914 AND DT 2017 AND VI 35 AND IP 4
Results: 15
1
2
Gender-related differences in antiplatelet treatment patterns and outcome: Insights from the GReekAntiPlatElet Registry.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12270
- By:
- Publication type:
- Article
3
Association of body mass index with mortality in Chinese patients after percutaneous coronary intervention: A large single-center data.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12271
- By:
- Publication type:
- Article
4
Endothelial damage effects of circulating microparticles from patients with stable angina are reduced by aspirin through ERK/p38 MAPKs pathways.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12273
- By:
- Publication type:
- Article
5
Pharmacogenomics of angiotensin receptor/neprilysin inhibitor and its long-term side effects.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12272
- By:
- Publication type:
- Article
6
Effects of clopidogrel on inflammatory cytokines and adhesion molecules in human endothelial cells: Role of nitric oxide mediating pleiotropic effects.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12261
- By:
- Publication type:
- Article
7
Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12263
- By:
- Publication type:
- Article
8
Visit-to-visit systolic blood pressure variability predicts treatment-related adverse event of hyponatremia in SPRINT.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12274
- By:
- Publication type:
- Article
9
RVX 208: A novel BET protein inhibitor, role as an inducer of apo A-I/ HDL and beyond.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12265
- By:
- Publication type:
- Article
10
Pulmonary vein isolation with concomitant renal artery denervation is associated with reduction in both arterial blood pressure and atrial fibrillation burden: Data from implantable cardiac monitor.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12264
- By:
- Publication type:
- Article
11
Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-'Expanding arena for ivabradine'.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12266
- By:
- Publication type:
- Article
12
Assessment of vascular response to Bi OSS LIM C<sup>®</sup> stents vs Orsiro<sup>®</sup> stents in the porcine coronary artery model.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12267
- By:
- Publication type:
- Article
13
Aspirin responsiveness changes in obese patients following bariatric surgery.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12268
- By:
- Publication type:
- Article
14
The use of an occlusion perfusion catheter to deliver paclitaxel to the arterial wall.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12269
- By:
- Publication type:
- Article
15
Issue Information.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 4, p. n/a, doi. 10.1111/1755-5922.12219
- Publication type:
- Article